Finance

Lists
Why is ZLDPF down २.२१%?
Dive Deeper
ZLDPF:OTCMKTS
Zealand Pharma A/S
US$ ३४.६०
-२.२१%
(-०.७८) 1D
नोभेम्बर ६, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZLDPF...
Open
US$ ३४.६०
High
US$ ३४.६०
Low
US$ ३४.६०
Mkt. cap
२.५४ अरब
Avg. vol.
४०३.००
Volume
०.००
52-wk high
US$ ८३.१२
52-wk low
US$ ३३.०८
Beta
१.२५
Shares outstanding
७.१६ करोड
No. of employees
५७८
Open
US$ ३४.६०
High
US$ ३४.६०
Low
US$ ३४.६०
Mkt. cap
२.५४ अरब
Avg. vol.
४०३.००
Volume
०.००
52-wk high
US$ ८३.१२
52-wk low
US$ ३३.०८
Beta
१.२५
Shares outstanding
७.१६ करोड
No. of employees
५७८
News stories
From web sources and news partners
صحيفة مال
صحيفة مال
·
८ मिनेट पहिले
Nasdaq rebounds but posts fourth straight weekly decline
Investor's Business Daily
Investor's Business Daily
·
५ घण्टा पहिले
Futures: Market Needs Repair; These Big Winners Are Broken
Fox Business
Fox Business
·
१० घण्टा पहिले
Nasdaq rallies as chip stocks recover from brutal losses
Seeking Alpha
Seeking Alpha
·
३ घण्टा पहिले
Regression To Trend: S&P Composite 213% Above Trend In October
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S
CEOAdam Steensberg
Employees५७८
Founded१९९७ अप्रिल १
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
४.९६ करोड
६.८९ करोड
३.४० करोड
४.४९ अरब
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
३२.०० करोड
५३.०१ करोड
४६.९० करोड
५१.६० करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१९.०९ करोड
९.१८ करोड
१०.४० करोड
११.६० करोड
Operating expense
५१.०९ करोड
६२.१९ करोड
५७.३० करोड
६३.२० करोड
Total operating expenses
५१.०९ करोड
६२.१९ करोड
५७.३० करोड
६३.२० करोड
Operating income
-४६.१३ करोड
-५५.३० करोड
-५३.९० करोड
३.८६ अरब
Other non operating income
-१.७६ करोड
-७२.२६ लाख
२.४० करोड
-९.१० करोड
EBT including unusual items
-३६.६७ करोड
-४०.६५ करोड
-३९.४० करोड
४.०१ अरब
EBT excluding unusual items
-३८.३६ करोड
-४६.०२ करोड
-३७.५० करोड
३.९७ अरब
Income tax expense
३.७५ करोड
-२.७४ करोड
-
८.९० करोड
Effective tax rate
-१०.२३%
६.७४%
-
२.२२%
Other operating expenses
-
१.०० हजार
-
-
Net income
-४०.४२ करोड
-३७.९१ करोड
-३९.४० करोड
३.९२ अरब
Net profit margin
-८१५.५०%
-५५०.१२%
-१,१५८.८२%
८७.२२%
Earnings per share
-५.७५
-५.१९
-५.५८
५५.३४
Interest and investment income
१०.८९ करोड
१०.२४ करोड
७.४० करोड
७.२० करोड
Interest expense
-६९.९७ लाख
-७०.७१ लाख
-५०.०० लाख
-८०.०० लाख
Net interest expenses
१०.२० करोड
९.५३ करोड
६.९० करोड
६.४० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
-४५.४१ करोड
-५५.०५ करोड
-५२.९० करोड
३.८७ अरब
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू